Robert S. DiPaola

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci et al. · New England Journal of Medicine · 2015 · 2.8K citations · Full text

Medicine, Oncology, Urology +15

Autophagy Suppresses Tumorigenesis through Elimination of p62

Robin Mathew, Cristina M. Karp, Brian Beaudoin et al. · Cell · 2009 · 1.7K citations · Full text

Life Sciences, Cancer Biology, Cell Biology +12

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis

Jessie Yanxiang Guo, Hsin-Yi Chen, Robin Mathew et al. · Genes & Development · 2011 · 1.3K citations · Full text

Medicine, Cancer Biology, Oncology +17

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Christos E. Kyriakopoulos, Yu‐Hui Chen, Michael A. Carducci et al. · Journal of Clinical Oncology · 2018 · 1.1K citations · Full text

Medicine, Oncology, Urology +17

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

Naomi B. Haas, Judith Manola, Robert G. Uzzo et al. · The Lancet · 2016 · 638 citations

Medicine, Oncology, Pharmacology +14